프로그램

Updated as of Feb-20, 2019


인사말    유희석 (대한암학회 회장) 09:00-09:10
1. Dissecting tumor immune microenvironment 09:10-10:40
  좌장: 임종석 (숙명여대 이과대)
1) Impact of tumor-associated macrophages (TAM) in tumor hypoxia and aerobic glycolysis
안지완 (포항공대)
2) Reconstructing the tumor microenvironment using high dimensional single-cell analysis
Michael Wong (MSD)
3) Understanding the biology of the TME using genomic analyses of tumor cells
Steven M. Townson (MSD/Merck research Lab)
Coffee Break 10:40-11:00
2. Strategies to overcome immune resistance 11:00-12:30
  좌장: 정현철 (연세의대)
1) Complex adaptive cancer immunotherapy
김인산 (한국과학기술연구원)
2) Myeloid-derived suppressor cells: A new therapeutic target to overcome resistance to checkpoint blockade therapy
연제인 (프로젠)
3) Oncolytic virus in cancer immunotherapy
라선영 (연세의대)
Luncheon Symposia
  Luncheon Symposium 1 – Presented by Roche 12:30-13:30
  좌장: 강진형 (가톨릭의대)
How immunotherapy is revolutionising 1L and 2L lung cancer care
  정현애 (성균관의대)
  Luncheon Symposium 2 – Presented by ONO/BMS 12:30-13:30
  좌장: 장대영 (한림의대)
  Bringing clarity to clinical decisions in RCC and GC: Translating data into practice
  배우균 (전남의대)
3. Recent advances in cancer immunotherapy 13:40-15:10
  좌장: 박경화 (고려의대)
1) State of GBM immunotherapy
Michael Lim (Johns Hopkins University School of Medicine)
2) Evidences of IO combination with standard of care: Lessons from breast cancer
박인혜 (국립암센터)
3) Genomics! Is immunotherapy right for me?
이대호 (울산의대)
Coffee Break 15:10-15:30
4. Developmental therapeutics in immuno-oncology 15:30-17:00
  좌장: 강창율 (서울대 약대)
1) Enhancing cancer immunotherapy using biomaterials
박천권 (성균관대)
2) NK cell-based cancer immunotherapy for refractory cancer
최인표 (한국생명공학연구원)
3) Development of small molecule based immunotherapeutics for innovative anti-cancer treatment
이창훈 (한국화학연구원)
4) PharmAbcine and its immuno-oncology strategy
유진산 (파멥신)